loadpatents
Patent applications and USPTO patent grants for YAN; Hongbin.The latest application filed is for "use of rivastigmine in preparation of anti-radiation medicament".
Patent | Date |
---|---|
Use Of Rivastigmine In Preparation Of Anti-radiation Medicament App 20220175714 - CHEN; Qiu ;   et al. | 2022-06-09 |
Use of fluorinated cyclic dinucleotides as oral vaccine adjuvants Grant 10,357,560 - Yan , et al. July 23, 2 | 2019-07-23 |
Use Of Fluorinated Cyclic Dinucleotides As Oral Vaccine Adjuvants App 20190015502 - Yan; Hongbin ;   et al. | 2019-01-17 |
Use of fluorinated cyclic dinucleotides as oral vaccine adjuvants Grant 10,092,644 - Yan , et al. October 9, 2 | 2018-10-09 |
Long-acting blood sugar decreasing fusion protein Grant 10,017,555 - Zhou , et al. July 10, 2 | 2018-07-10 |
Use Of Fluorinated Cyclic Dinucleotides As Oral Vaccine Adjuvants App 20160287698 - YAN; Hongbin ;   et al. | 2016-10-06 |
Long-Acting Blood Sugar Decreasing Fusion Protein App 20160222079 - ZHOU; Joe ;   et al. | 2016-08-04 |
Compounds for fluorescent labeling Grant 8,519,153 - Yan , et al. August 27, 2 | 2013-08-27 |
Compounds For Fluorescent Labeling App 20120071644 - Yan; Hongbin ;   et al. | 2012-03-22 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.